文献速递糖尿病

自噬通过调控Foxo1蛋白丰度参与胰高血糖素信号下的肝糖生成

Autophagy Regulates Foxo1 Protein Abundance to Control Hepatic Glucose Production in Glucagon Signalling
RSS 订阅 · Diabetes, Obesity and Metabolism · 2026-10-09

该研究在小鼠和原代肝细胞中抑制自噬,观察其对胰高血糖素-Foxo1信号及肝糖生成的影响。结果显示,抑制自噬可降低丙酮酸刺激的血糖升高和肝细胞葡萄糖生成,并减弱胰高血糖素相关的糖异生及脂肪酸氧化基因表达。机制上,自噬抑制降低Foxo1蛋白丰度并损害肝内氨基酸稳态,外源氨基酸补充可部分恢复Foxo1蛋白水平和肝糖生成。

要点

  • 自噬抑制可降低丙酮酸刺激的肝糖生成,并减弱胰高血糖素相关基因表达。
  • 自噬通过维持肝内氨基酸稳态来稳定Foxo1蛋白丰度。
  • 外源氨基酸补充可部分恢复自噬抑制下的Foxo1蛋白水平和肝糖生成。

核心结论

  • 自噬调控的氨基酸稳态是维持Foxo1蛋白丰度并支持胰高血糖素应答性肝代谢适应的重要机制。

研究设计与样本

  • 使用羟氯喹和AAV8-shRNA-Atg7抑制小鼠自噬,使用氯喹和siRNA-Atg7抑制小鼠原代肝细胞自噬。
  • 实验对象包括对照小鼠和肝脏特异性Foxo1敲除小鼠。
  • 开展丙酮酸和胰高血糖素耐受试验、肝糖生成测定、基因表达分析、蛋白质印迹和HPLC氨基酸测定。

主要发现

  • 抑制自噬降低小鼠丙酮酸刺激的血糖升高和离体原代肝细胞的葡萄糖生成。
  • 抑制自噬在体内显示降低胰高血糖素刺激的血糖升高的趋势。
  • 抑制自噬减弱原代肝细胞中胰高血糖素应答的糖异生和脂肪酸氧化相关基因表达。
  • 在Foxo1缺陷模型中,自噬抑制的上述效应明显减弱。
  • 抑制自噬显著降低Foxo1蛋白丰度,并伴随肝内氨基酸稳态受损,但Foxo1基因表达无相应变化。

临床怎么用

  • 在评估胰高血糖素信号或肝糖生成调节时,需考虑自噬和肝内氨基酸稳态对Foxo1蛋白丰度的影响。

局限性

  • 自噬抑制导致的Foxo1蛋白减少不能完全由蛋白酶体依赖性降解解释。
  • 自噬抑制对胰高血糖素刺激的体内血糖升高的影响仅为趋势,未达到明确显著水平。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ABSTRACT Aim During fasting, the liver undergoes coordinated metabolic adaptations to maintain systemic energy homeostasis. These adaptations are driven in part by glucagon, which promotes hepatic glucose production (HGP) and fatty acid oxidation (FAO) through mechanisms involving the transcription factor Foxo1. Autophagy is also activated during nutrient deprivation and maintains intracellular nutrient availability by recycling cellular components. However, whether autophagy supports glucagon-Foxo1 signalling and the associated hepatic metabolic responses remains unclear. Materials and Methods Hydroxychloroquine sulphate (HCQ) and AAV8-shRNA-Atg7 were used to inhibit autophagy in control and liver-specific Foxo1 knockout (L-FKO) mice, and chloroquine (CQ) and siRNA-Atg7 were used to inhibit autophagy in mouse primary hepatocytes. Pyruvate and glucagon tolerance tests were performed in mice. HGP assays, gene expression analysis, western blotting and HPLC-based amino acid measurements were conducted to evaluate glucose production, Foxo1 signalling, gluconeogenic and FAO-related pathways and amino acid availability. Results We found that inhibition of autophagy reduced pyruvate-stimulated glucose excursions in mice and glucose production in isolated primary hepatocytes, while showing a trend towards reducing glucagon-stimulated glucose excursions in vivo. It also attenuated glucagon-responsive gluconeogenic and FAO-related gene expression in primary hepatocytes. However, these effects of autophagy inhibition were markedly blunted in Foxo1-deficient models. Mechanistically, suppression of autophagy significantly decreased Foxo1 protein abundance in association with impaired hepatic amino acid homeostasis, without corresponding changes in Foxo1 gene expression and not fully explained by proteasome-dependent degradation. Importantly, supplementation with exogenous amino acids restored Foxo1 protein levels by 1.89-fold under basal conditions and 1.35-fold under glucagon-treated conditions (p < 0.05), and partially rescued HGP under autophagy-inhibited conditions. Conclusion These findings identify autophagy-regulated amino acid homeostasis as a critical mechanism that sustains Foxo1 protein abundance and supports glucagon-responsive hepatic metabolic adaptation during fasting.

来源:Diabetes, Obesity and Metabolism,查看原文。版权归原作者所有。

引用

  1. Diabetes, Obesity and Metabolism:Autophagy Regulates Foxo1 Protein Abundance to Control Hepatic Glucose Production in Glucagon Signalling

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。